MedPath

Impact of Hypericum ointment on perineal pain and episiotomy healing

Phase 3
Conditions
Episiotomy.
Disruption of perineal obstetric wound
Registration Number
IRCT201404085912N15
Lead Sponsor
Research department of Tehran University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
84
Inclusion Criteria

Full term singleton pregnancy with cephalic presentation; absence of rapid or prolonged labor; absence of membranes for more than 18 hours; mediolateral episiotomy without rupture and spread with same amount of Lidocaine; lack of visible damage or defects in the perineal area; Absence of illness, addiction and drugs that influence on wound healing; Spontaneous and complete placenta outflow; Apparently healthy infant with normal weight; and Exclusion criteria: Episiotomy hematoma in the first 24 hours after childbirth; failure to use the correct and consistent command of Hypericum ointment and placebo; unwillingness to continue participating in the study; sensitivity to ointments; having sexual relation for the first 10 days of postpartum.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain intensity. Timepoint: 4 hours after episiotomy, 8 hours after episiotomy, 12 hours after episiotomy, 5 days after episiotomy, 10 days after episiotomy. Method of measurement: Visual Analouge Scale.;Healing of episiotomy. Timepoint: Before intervention, 5 and 10 days after episiotomy. Method of measurement: REEDA Scale of wound healing.
Secondary Outcome Measures
NameTimeMethod
Sedative tablets counting. Timepoint: Tenth day after delivery. Method of measurement: Counted tablets.
© Copyright 2025. All Rights Reserved by MedPath